Biology:Interleukin-1 receptor antagonist protein

From HandWiki
Short description: Protein and coding gene in humans


A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example

The interleukin-1 receptor antagonist protein (IL-1RN) is a protein that in humans is encoded by the IL1RN gene.[1][2]

IL-1RN was initially called the IL-1 inhibitor and was discovered separately in 1984 by two independent laboratories.[3] IL-1RN is an agent that binds non-productively to the cell surface interleukin-1 receptor (IL-1R), the same receptor that binds interleukin 1 family (IL-1), preventing IL-1's from sending a signal to that cell.

Function

IL-1RA is a member of the interleukin 1 cytokine family. IL1Ra is secreted by various types of cells including immune cells, epithelial cells, and adipocytes, and is a natural inhibitor of the pro-inflammatory effect of IL1β.[4] This protein inhibits the activities of interleukin 1, alpha (IL1A) and interleukin 1, beta (IL1B), and modulates a variety of interleukin 1 related immune and inflammatory responses. This gene and five other closely related cytokine genes form a gene cluster spanning approximately 400 kb on chromosome 2. Four alternatively spliced transcript variants encoding distinct isoforms have been reported.[5]

Clinical significance

A polymorphism of this gene is reported to be associated with increased risk of osteoporotic fractures[6] and gastric cancer.[7]

Mutations in the IL1RN gene results in a rare disease called deficiency of the interleukin-1–receptor antagonist (DIRA).[8] Variants of the IL1RN gene is also associated with risk of schizophrenia.[9][10] Elevated levels of IL1RN has been found in serum of schizophrenia patients.[11]

A recombinant, slightly modified version of interleukin 1 receptor antagonist called anakinra is used in the treatment of rheumatoid arthritis, an autoimmune disease in which IL-1 plays a key role.[12] Anakinra differs from native human IL-1Ra in that it has the addition of a single methionine residue at its amino terminus [13]

Use in horses

Interleukin 1 receptor antagonist is used in horses for the treatment of equine lameness secondary to joint and soft-tissue injury.

References

  1. "The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci". Genomics 13 (3): 654–7. July 1992. doi:10.1016/0888-7543(92)90137-H. PMID 1386337. 
  2. "The human interleukin-1 receptor antagonist (IL1RN) gene is located in the chromosome 2q14 region". Genomics 15 (1): 173–6. January 1993. doi:10.1006/geno.1993.1025. PMID 8432529. 
  3. Dinarello CA (December 1994). "The interleukin-1 family: 10 years of discovery". FASEB J. 8 (15): 1314–25. doi:10.1096/fasebj.8.15.8001745. PMID 8001745. 
  4. "IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?". FEBS Lett. 580 (27): 6289–94. November 2006. doi:10.1016/j.febslet.2006.10.061. PMID 17097645. 
  5. "Entrez Gene: IL1RN interleukin 1 receptor antagonist". https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3557. 
  6. "Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene". J. Bone Miner. Res. 15 (3): 402–14. March 2000. doi:10.1359/jbmr.2000.15.3.402. PMID 10750554. 
  7. "Interleukin-1 polymorphisms associated with increased risk of gastric cancer". Nature 404 (6776): 398–402. March 2000. doi:10.1038/35006081. PMID 10746728. http://digitalcommons.unl.edu/cgi/viewcontent.cgi?article=1131&context=publichealthresources. 
  8. "An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist". N. Engl. J. Med. 360 (23): 2426–37. June 2009. doi:10.1056/NEJMoa0807865. PMID 19494218. 
  9. "Impact of IL-1 receptor antagonist gene polymorphism on schizophrenia and bipolar disorder". Psychiatr. Genet. 14 (3): 165–7. September 2004. doi:10.1097/00041444-200409000-00009. PMID 15318032. 
  10. "Association between IL-1beta -511C/T and IL-1RA (86bp)n repeats polymorphisms and schizophrenia". J Psychiatr Res 37 (6): 457–62. 2003. doi:10.1016/S0022-3956(03)00072-4. PMID 14563376. 
  11. "Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor". Bipolar Disord 11 (7): 726–34. November 2009. doi:10.1111/j.1399-5618.2009.00757.x. PMID 19839997. 
  12. "Anakinra for rheumatoid arthritis". The Cochrane Database of Systematic Reviews (1): CD005121. January 2009. doi:10.1002/14651858.CD005121.pub3. PMID 19160248. 
  13. "Kineret (anakinra) injection, for subcutaneous use". Swedish Orphan Biovitrum. http://www.kineretrx.com/pdf/Full-Prescribing-Information-English.pdf. 

Further reading

External links